>
New image sheds light on China's secret spaceplane
France to Impose 'Riot Tax' on Insurance to Pay for Damage of Islamo-Leftist Unrest
A3Podcast Special Report 30 Oct 26 - Increased Risk
Microreactor Gets DOE Approval for Full Power Testing, Previously Contracts with Army...
Microreactor Gets DOE Approval for Full Power Testing, Previously Contracts with Army...
Ford Fathom: Everything We Know About The Sub-$30,000 Affordable EV Truck
Love it or loathe it, AI is birthing a golden age of science
SpaceX has no competition -- Saurav Shroff, Starpath
Living computers forge a 'hive mind' and work together to outsmart AI
The Faraday duffle bag: A digital lifeline in a surveillance-saturated world
Delivery Robots Accused Of Scanning Customers' Faces, Sharing Biometric Data
Brace Yourselves: Serious Trouble Brewing In The Data Center Industry
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial
California Startup Says It Has Injected AI-Designed Virus Into Humans For First Time

Developed by researchers in the US, the remarkable new treatment could one day be used to treat patients in advanced stages of dementia by restoring the brain's ability to recover from ongoing neurodegeneration.
"The new neurons can become mature and survive," says senior author Peisheng Xu, a pharmaceutical researcher at the University of South Carolina.
"We also confirmed much higher neuron density in the brains of treated mice."
Alzheimer's disease is a battle between cell growth and the steady loss of neurons to inflammation. Because the brain can't quickly replace lost nerve cells in critical areas such as the hippocampus, people with the disease lose memory, cognition, and eventually the ability to feed or safely maintain balance.